CARDIFF ONCOLOGY, INC. General and Administrative Expense
CARDIFF ONCOLOGY, INC. (CRDF) reported General and Administrative Expense of $11.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2018-02-26
- CARDIFF ONCOLOGY, INC. general and administrative expense for the quarter ending 2017-12-31 was $1.58M, a 30.98% decline year-over-year.
- CARDIFF ONCOLOGY, INC. general and administrative expense for the quarter ending 2017-09-30 was $3.66M, a 35.00% increase year-over-year.
- CARDIFF ONCOLOGY, INC. general and administrative expense for the quarter ending 2017-06-30 was $4.06M, a 64.42% increase year-over-year.
- CARDIFF ONCOLOGY, INC. general and administrative expense for the quarter ending 2017-03-31 was $2.20M, a 45.14% decline year-over-year.
- CARDIFF ONCOLOGY, INC. general and administrative expense for fiscal 2017 was $11.50M, a 0.19% increase from fiscal 2016.
- CARDIFF ONCOLOGY, INC. general and administrative expense for fiscal 2016 was $11.48M, a 44.90% increase from fiscal 2015.
- CARDIFF ONCOLOGY, INC. general and administrative expense for fiscal 2015 was $7.92M, a 36.31% increase from fiscal 2014.
- CARDIFF ONCOLOGY, INC. general and administrative expense for fiscal 2014 was $5.81M, a 6.18% increase from fiscal 2013.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 6 month as first filed | General and Administrative Expense 9 month | General and Administrative Expense 9 month as first filed | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed | General and Administrative Expense 152 month | General and Administrative Expense 155 month | General and Administrative Expense 158 month | General and Administrative Expense 161 month | General and Administrative Expense 164 month | General and Administrative Expense 167 month | General and Administrative Expense 170 month | General and Administrative Expense 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.24M derived: sum of 2 quarters · filed 2018-02-26 | $9.30M derived: sum of 3 quarters · filed 2018-02-26 | $11.50M 10-K · filed 2018-02-26 | ||||||||||||
| 2017-09-30 | $3.66M 10-Q · filed 2017-11-09 | $7.72M derived: sum of 2 quarters · filed 2017-11-09 | $9.92M 10-Q · filed 2017-11-09 | $12.21M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2017-06-30 | $4.06M 10-Q · filed 2017-08-09 | $6.26M 10-Q · filed 2017-08-09 | $8.55M derived: sum of 3 quarters · filed 2018-02-26 | $11.26M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2017-03-31 | $2.20M 10-Q · filed 2017-05-10 | $4.49M derived: sum of 2 quarters · filed 2018-02-26 | $7.20M derived: sum of 3 quarters · filed 2018-02-26 | $9.67M derived: sum of 4 quarters · filed 2018-02-26 | ||||||||||||
| 2016-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.00M derived: sum of 2 quarters · filed 2018-02-26 | $7.47M derived: sum of 3 quarters · filed 2018-02-26 | $11.48M 10-K · filed 2018-02-26 | ||||||||||||
| 2016-09-30 | $2.71M 10-Q · filed 2017-11-09 | $5.18M derived: sum of 2 quarters · filed 2017-11-09 | $9.18M 10-Q · filed 2017-11-09 | $11.35M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||
| 2016-06-30 | $2.47M 10-Q · filed 2017-08-09 | $6.47M 10-Q · filed 2017-08-09 | $8.64M derived: sum of 3 quarters · filed 2017-08-09 | $10.59M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||||||
| 2016-03-31 | $4.00M 10-Q · filed 2017-05-10 | $6.17M derived: sum of 2 quarters · filed 2017-05-10 | $8.12M derived: sum of 3 quarters · filed 2017-05-10 | $10.12M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||||
| 2015-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $4.11M derived: sum of 2 quarters · filed 2017-03-15 | $6.11M derived: sum of 3 quarters · filed 2017-03-15 | $7.92M 10-K · filed 2017-03-15 | ||||||||||||
| 2015-09-30 | $1.95M 10-Q · filed 2016-11-09 | $3.95M derived: sum of 2 quarters · filed 2016-11-09 | $5.76M 10-Q · filed 2016-11-09 | $7.43M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-04 | $3.81M 10-Q · filed 2016-08-04 | $5.48M derived: sum of 3 quarters · filed 2017-03-15 | $6.95M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2015-03-31 | $1.81M 10-Q · filed 2016-05-10 | $3.48M derived: sum of 2 quarters · filed 2017-03-15 | $4.95M derived: sum of 3 quarters · filed 2017-03-15 | $6.26M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||
| 2014-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $3.14M derived: sum of 2 quarters · filed 2017-03-15 | $4.45M derived: sum of 3 quarters · filed 2017-03-15 | $5.81M 10-K · filed 2017-03-15 | ||||||||||||
| 2014-09-30 | $1.47M 10-Q · filed 2015-11-09 | $2.78M derived: sum of 2 quarters · filed 2015-11-09 | $4.14M 10-Q · filed 2015-11-09 | $5.37M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||||
| 2014-06-30 | $1.31M 10-Q · filed 2015-08-10 | $2.67M 10-Q · filed 2015-08-10 | $3.90M derived: sum of 3 quarters · filed 2016-03-10 | $5.78M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||||
| 2014-03-31 | $1.36M 10-Q · filed 2015-05-05 | $2.59M derived: sum of 2 quarters · filed 2016-03-10 | $4.47M derived: sum of 3 quarters · filed 2016-03-10 | $5.48M derived: sum of 4 quarters · filed 2016-03-10 | $32.24M 10-Q · filed 2014-05-12 | |||||||||||
| 2013-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $3.11M derived: sum of 2 quarters · filed 2016-03-10 | $4.13M derived: sum of 3 quarters · filed 2016-03-10 | $5.47M 10-K · filed 2016-03-10 | ||||||||||||
| 2013-09-30 | $1.88M 10-Q · filed 2014-11-06 | $2.21M 10-Q · filed 2013-11-14 | $2.89M derived: sum of 2 quarters · filed 2014-11-06 | $4.24M 10-Q · filed 2014-11-06 | $5.39M 10-Q · filed 2013-11-14 | $4.73M derived: sum of 4 quarters · filed 2015-03-12 | $31.31M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $1.01M 10-Q · filed 2014-08-07 | $1.48M 10-Q · filed 2013-08-14 | $2.36M 10-Q · filed 2014-08-07 | $3.19M 10-Q · filed 2013-08-14 | $2.86M derived: sum of 3 quarters · filed 2015-03-12 | $3.60M derived: sum of 4 quarters · filed 2015-03-12 | $29.11M 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $1.35M 10-Q · filed 2014-05-12 | $1.71M 10-Q · filed 2013-05-14 | $1.84M derived: sum of 2 quarters · filed 2015-03-12 | $2.58M derived: sum of 3 quarters · filed 2015-03-12 | $3.39M derived: sum of 4 quarters · filed 2015-03-12 | $27.63M 10-Q · filed 2013-05-14 | ||||||||||
| 2012-12-31 | $497.06K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.24M derived: sum of 2 quarters · filed 2015-03-12 | $2.05M derived: sum of 3 quarters · filed 2015-03-12 | $2.87M 10-K · filed 2015-03-12 | $3.38M 10-K · filed 2013-04-01 | $25.92M 10-K · filed 2013-04-01 | ||||||||||
| 2012-09-30 | $739.04K 10-Q · filed 2013-11-14 | $1.55M derived: sum of 2 quarters · filed 2013-11-14 | $2.38M 10-Q · filed 2013-11-14 | $2.98M derived: sum of 4 quarters · filed 2013-11-14 | $24.92M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $809.87K 10-Q · filed 2013-08-14 | $1.64M 10-Q · filed 2013-08-14 | $2.24M derived: sum of 3 quarters · filed 2013-08-14 | $2.83M derived: sum of 4 quarters · filed 2013-08-14 | $24.18M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $826.96K 10-Q · filed 2013-05-14 | $1.43M derived: sum of 2 quarters · filed 2013-05-14 | $2.02M derived: sum of 3 quarters · filed 2013-05-14 | $2.60M derived: sum of 4 quarters · filed 2013-05-14 | $23.37M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $602.51K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $1.19M derived: sum of 2 quarters · filed 2013-04-01 | $1.77M derived: sum of 3 quarters · filed 2013-04-01 | $2.32M 10-K · filed 2013-04-01 | ||||||||||||
| 2011-09-30 | $586.23K 10-Q · filed 2012-11-14 | $1.17M derived: sum of 2 quarters · filed 2012-11-14 | $1.72M 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $584.02K 10-Q · filed 2012-08-14 | $1.14M 10-Q · filed 2012-08-14 | ||||||||||||||
| 2011-03-31 | $551.04K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |